Skip to main content
Top
Published in: Acta Neurologica Belgica 3/2020

01-06-2020 | Original Article

An investigation on the effects of carbamazepine and sodium valproate on neuromuscular transmission

Authors: Halil Ay, Özlem Ethemoğlu

Published in: Acta Neurologica Belgica | Issue 3/2020

Login to get access

Abstract

The aim of this study was to investigate the effects of sodium valproate (SV) and carbamazepine (CBZ) on neuromuscular transmission using single-fibre electromyography (SFEMG) in patients with epilepsy. We performed SFEMG during the voluntary contraction of extensor digitorum communis muscle. 30 epileptic patients taking SV, 25 epileptic patients taking CBZ, and 25 age-matched healthy volunteers were included in the study. Mean jitter values (MCD) of subjects taking SV and CBZ were compared with normal controls. MCD values of subjects taking SV and CBZ were statistically significantly higher than those of control group. Review of the correlation between disease duration and MCD values of patients showed that MCD values were increased with the prolonged use of drugs, and thus, indicated a positive relationship between these two parameters. These results suggest that both SV and CBZ reduce neuromuscular transmission in patients without a neuromuscular junction disease.
Literature
1.
go back to reference Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 14(10):1023–1036CrossRef Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol. 14(10):1023–1036CrossRef
2.
go back to reference Losavio A, Muchnik S (1997) Spontaneous acetylcholine release in mammalian neuromuscular junctions. Am J Physiol 273:1835–1841CrossRef Losavio A, Muchnik S (1997) Spontaneous acetylcholine release in mammalian neuromuscular junctions. Am J Physiol 273:1835–1841CrossRef
3.
go back to reference Flucher BE, Daniels MP (1989) Distribution of Na+ channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kd protein. Neuron. 3:163–175CrossRef Flucher BE, Daniels MP (1989) Distribution of Na+ channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kd protein. Neuron. 3:163–175CrossRef
4.
go back to reference Bora İ (2008) Epilepsi Nobel tıp kitap evi, birinci baskı 600 Bora İ (2008) Epilepsi Nobel tıp kitap evi, birinci baskı 600
5.
go back to reference Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 16(10):695–714CrossRef Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 16(10):695–714CrossRef
6.
go back to reference Broicher T, Seidenbecher T, Meuth P, Munsch T, Meuth SG, Kanyshkova T, Pape HC, Budde T (2007) T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy. Neuropharmacology 53:431–446CrossRef Broicher T, Seidenbecher T, Meuth P, Munsch T, Meuth SG, Kanyshkova T, Pape HC, Budde T (2007) T-current related effects of antiepileptic drugs and a Ca2+ channel antagonist on thalamic relay and local circuit interneurons in a rat model of absence epilepsy. Neuropharmacology 53:431–446CrossRef
7.
go back to reference VanDongen AM, VanErp MG, Voskuyl RA (1986) Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia. 27:177–182CrossRef VanDongen AM, VanErp MG, Voskuyl RA (1986) Valproate reduces excitability by blockage of sodium and potassium conductance. Epilepsia. 27:177–182CrossRef
8.
go back to reference Spiller HA, Carlisle RD (2002) Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol 40:81–90CrossRef Spiller HA, Carlisle RD (2002) Status epilepticus after massive carbamazepine overdose. J Toxicol Clin Toxicol 40:81–90CrossRef
9.
go back to reference Perucca E (2001) Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol 15:405–417CrossRef Perucca E (2001) Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol 15:405–417CrossRef
10.
go back to reference Cherian Ajith, Baheti Neeraj N, Iype Thomas (2013) Electrophysiological study in neuromuscular junction disorders. Ann Indian Acad Neurol 16(1):34–41CrossRef Cherian Ajith, Baheti Neeraj N, Iype Thomas (2013) Electrophysiological study in neuromuscular junction disorders. Ann Indian Acad Neurol 16(1):34–41CrossRef
11.
go back to reference Stalberg E, Sanders DB, Ali S, Cooray G, Leonardis L, Löseth S, Machado F, Maldonado A, Martinez-Aparicio C, Sandberg A, Smith B, Widenfalk J, Aris Kouyoumdjian J (2016) Reference values for jitter recorded by concentric needle electrodes in healthy controls: a multicenter study. Muscle Nerve 53(3):351–362CrossRef Stalberg E, Sanders DB, Ali S, Cooray G, Leonardis L, Löseth S, Machado F, Maldonado A, Martinez-Aparicio C, Sandberg A, Smith B, Widenfalk J, Aris Kouyoumdjian J (2016) Reference values for jitter recorded by concentric needle electrodes in healthy controls: a multicenter study. Muscle Nerve 53(3):351–362CrossRef
12.
go back to reference Boneva N, Brenner T, Argov Z (2000) Gabapentin may be hazardous in myasthenia gravis. Muscle Nerve 23:1204–1208CrossRef Boneva N, Brenner T, Argov Z (2000) Gabapentin may be hazardous in myasthenia gravis. Muscle Nerve 23:1204–1208CrossRef
13.
go back to reference So EL, Penry JK (1981) Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review. Epilepsia 22:467–473CrossRef So EL, Penry JK (1981) Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review. Epilepsia 22:467–473CrossRef
14.
go back to reference Kurian MA, King MD (2003) Antibody positive myasthenia gravis following treatment with carbamazepine—a chance association? Neuropediatrics 34:276–277CrossRef Kurian MA, King MD (2003) Antibody positive myasthenia gravis following treatment with carbamazepine—a chance association? Neuropediatrics 34:276–277CrossRef
15.
go back to reference Rasmussen M (2004) Carbamazepine and myasthenia gravis. Neuropediatrics 35:259CrossRef Rasmussen M (2004) Carbamazepine and myasthenia gravis. Neuropediatrics 35:259CrossRef
16.
go back to reference Losavio A, Muchnik S (1997) Spontaneous acetylcholine release in mammalian neuromuscular junctions. Am J Physiol 273:1835–1841CrossRef Losavio A, Muchnik S (1997) Spontaneous acetylcholine release in mammalian neuromuscular junctions. Am J Physiol 273:1835–1841CrossRef
17.
go back to reference Alderdice MT, Trommer BA (1980) Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission. J Pharmacol Exp Ther 215(1):92–96PubMed Alderdice MT, Trommer BA (1980) Differential effects of the anticonvulsants phenobarbital, ethosuximide and carbamazepine on neuromuscular transmission. J Pharmacol Exp Ther 215(1):92–96PubMed
18.
go back to reference Ozkul Y (2007) Influence of calcium channel blocker drugs in neuromuscular transmission. Clin Neurophysiol 118:2005–2008CrossRef Ozkul Y (2007) Influence of calcium channel blocker drugs in neuromuscular transmission. Clin Neurophysiol 118:2005–2008CrossRef
19.
go back to reference Ambrosini A, Pierelli F, Schoenen J (2003) Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. Cephalalgia 23(2):75–78CrossRef Ambrosini A, Pierelli F, Schoenen J (2003) Acetazolamide acts on neuromuscular transmission abnormalities found in some migraineurs. Cephalalgia 23(2):75–78CrossRef
20.
go back to reference Murga L, Sanchez F, Menendez C, Castilla JM (1998) Diagnostic yield of stimulation and voluntary single fiber electromyography in myasthenia gravis. Muscle Nerve 21:1081–1083CrossRef Murga L, Sanchez F, Menendez C, Castilla JM (1998) Diagnostic yield of stimulation and voluntary single fiber electromyography in myasthenia gravis. Muscle Nerve 21:1081–1083CrossRef
21.
go back to reference Farrugia ME, Weir AI, Cleary M, Cooper S, Metcalfe R, Mallik A (2009) Concentric and single fiber needle electrodes yield comparable jitter results in myasthenia gravis. Muscle Nerve 39:579–585CrossRef Farrugia ME, Weir AI, Cleary M, Cooper S, Metcalfe R, Mallik A (2009) Concentric and single fiber needle electrodes yield comparable jitter results in myasthenia gravis. Muscle Nerve 39:579–585CrossRef
22.
go back to reference Ertaş M, Baslo MB, Yildiz N, Yazici J, Oge AE (2000) Concentric needle electrode for neuromuscular jitter analysis. Muscle Nerve 23:715–771CrossRef Ertaş M, Baslo MB, Yildiz N, Yazici J, Oge AE (2000) Concentric needle electrode for neuromuscular jitter analysis. Muscle Nerve 23:715–771CrossRef
23.
go back to reference Patten BM (1978) Myasthenia gravis: review of diagnosis and management. Muscle Nerve 1:190–205CrossRef Patten BM (1978) Myasthenia gravis: review of diagnosis and management. Muscle Nerve 1:190–205CrossRef
24.
go back to reference Rodriguez M, Gomez MR, Howard FM Jr, Taylor WF (1983) Myasthenia gravis in children. Ann Neurol 13:504–510CrossRef Rodriguez M, Gomez MR, Howard FM Jr, Taylor WF (1983) Myasthenia gravis in children. Ann Neurol 13:504–510CrossRef
25.
go back to reference Tartara A, Mola M, Manni R et al (1982) EEG findings in 118 cases of myasthenia gravis. Rev Electroencephalogr Neurophysiol Clin. 12:275–279CrossRef Tartara A, Mola M, Manni R et al (1982) EEG findings in 118 cases of myasthenia gravis. Rev Electroencephalogr Neurophysiol Clin. 12:275–279CrossRef
Metadata
Title
An investigation on the effects of carbamazepine and sodium valproate on neuromuscular transmission
Authors
Halil Ay
Özlem Ethemoğlu
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Acta Neurologica Belgica / Issue 3/2020
Print ISSN: 0300-9009
Electronic ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-017-0839-y

Other articles of this Issue 3/2020

Acta Neurologica Belgica 3/2020 Go to the issue